Guanhao Biotech Co.,Ltd. (SHE:300238)

Guanhao Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	141.43	106.78	105.14	126.28	159.31	156.2
Cash & Short-Term Investments	141.43	106.78	105.14	126.28	159.31	156.2
Cash Growth	32.62%	1.56%	-16.74%	-20.73%	1.99%	11.91%
Accounts Receivable	47.97	59.55	61.14	71.98	106.71	116.35
Other Receivables	1.05	2.21	13.36	8.74	11.04	14.36
Receivables	49.02	61.75	74.51	80.72	117.75	130.71
Inventory	83.5	78.46	71.6	61.68	140.55	126.9
Other Current Assets	26.78	18.8	16.03	30.22	17.81	24.22
Total Current Assets	300.73	265.79	267.28	298.89	435.41	438.03
Property, Plant & Equipment	321.54	332.47	252.04	214.6	245.54	220.63
Long-Term Investments	18.05	22.49	32.08	32.56	74.22	87.55
Goodwill	-	-	-	-	214.33	214.33
Other Intangible Assets	73.78	72.7	78.66	87.49	64.14	73.99
Long-Term Deferred Tax Assets	18.12	18.42	14.97	13.16	41.44	54.79
Long-Term Deferred Charges	32.65	29.88	24.17	23.58	23.66	29.82
Other Long-Term Assets	9.64	12.65	9.41	-	-	15.58
Total Assets	774.51	754.4	678.59	670.27	1,099	1,135
Accounts Payable	13.97	35.65	29.32	2.16	1.88	3.01
Accrued Expenses	14.25	59.45	58.01	52.96	83	76.53
Short-Term Debt	11.01	20.01	24.52	49.05	51.56	102.88
Current Portion of Long-Term Debt	5.09	0.09	-	-	54.69	50.17
Current Portion of Leases	-	5.64	6.07	7.49	9.51	-
Current Income Taxes Payable	8.53	4.71	3.96	13.72	14.62	2.61
Current Unearned Revenue	29.35	28.76	21.97	28.29	17.1	27.21
Other Current Liabilities	70.1	23.69	28.86	35.32	29.91	40.3
Total Current Liabilities	152.3	177.99	172.72	188.99	262.27	302.7
Long-Term Debt	100.95	76	12.02	-	-	54.6
Long-Term Leases	3.15	6.62	12.06	22.52	35.62	-
Long-Term Unearned Revenue	18.52	19.43	20.65	22.85	40.94	49.45
Long-Term Deferred Tax Liabilities	6.1	6.77	4.9	4.97	11.74	11.32
Total Liabilities	281.01	286.81	222.33	239.33	350.58	418.07
Common Stock	265.16	265.16	265.16	265.16	265.16	265.16
Additional Paid-In Capital	594.42	594.54	600.27	600.27	597.71	599.02
Retained Earnings	-241	-270.95	-298.37	-329.37	-21.57	-96.01
Comprehensive Income & Other	-46.46	-46.39	-46.46	-50.71	-57.38	-37.9
Total Common Equity	572.12	542.36	520.59	485.34	783.92	730.27
Minority Interest	-78.63	-74.77	-64.33	-54.4	-35.76	-13.61
Shareholders' Equity	493.49	467.59	456.26	430.94	748.16	716.66
Total Liabilities & Equity	774.51	754.4	678.59	670.27	1,099	1,135
Total Debt	120.2	108.35	54.67	79.06	151.38	207.64
Net Cash (Debt)	21.24	-1.57	50.47	47.22	7.93	-51.44
Net Cash Growth	144.89%	-	6.88%	495.52%	-	-
Net Cash Per Share	0.08	-0.01	0.20	0.18	0.03	-0.20
Filing Date Shares Outstanding	265.16	265.16	265.16	265.16	265.16	265.16
Total Common Shares Outstanding	265.16	265.16	265.16	265.16	265.16	265.16
Working Capital	148.43	87.8	94.56	109.9	173.14	135.33
Book Value Per Share	2.16	2.05	1.96	1.83	2.96	2.75
Tangible Book Value	498.34	469.66	441.93	397.85	505.45	441.95
Tangible Book Value Per Share	1.88	1.77	1.67	1.50	1.91	1.67
Buildings	-	392.83	225.53	239.59	239.59	245.94
Machinery	-	99.41	99.17	101.29	106.02	106.6
Construction In Progress	-	2.54	73.99	2.8	2.41	2.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.